155A.46 Statewide protocols.
1. a. A pharmacist may, pursuant to statewide protocols developed by the board in consultation with the department of public health and consistent with subsection 2, order and administer the following to patients ages eighteen years and older:
(1) Naloxone.
(2) Nicotine replacement tobacco cessation products.
(3) An immunization or vaccination recommended by the United States centers for disease control and prevention advisory committee on immunization practices in its approved vaccination schedule for adults.
(4) An immunization or vaccination recommended by the United States centers for disease control and prevention for international travel.
(5) A Tdap (tetanus, diphtheria, acellular pertussis) vaccination in a booster application.
(6) Other emergency immunizations or vaccinations in response to a public health emergency.
(7) An immunization or vaccination for COVID-19 as defined in section 686D.2.
b. A pharmacist may, pursuant to statewide protocols developed by the board in consultation with the department of public health and consistent with subsection 2, order and administer the following to patients ages six months and older:
(1) A vaccine or immunization for influenza.
(2) Other emergency immunizations or vaccines in response to a public health emergency.
c. A pharmacist may, pursuant to statewide protocols developed by the board in consultation with the department of public health and consistent with subsection 2, order and administer the final two doses in a course of vaccinations for HPV to patients ages eleven years and older.
d. Prior to the ordering and administration of a vaccination or immunization authorized by this subsection, pursuant to statewide protocols, a licensed pharmacist shall consult and review the statewide immunization registry or health information network. The board shall adopt rules requiring the reporting of the administration of vaccines and immunizations authorized by this subsection to a patient’s primary health care provider, primary physician, and a statewide immunization registry or health information network.
e. A pharmacist may, pursuant to statewide protocols developed by the board in consultation with the department of public health and consistent with subsection 2, order and administer the following to patients ages six years and older:
(1) Point-of-care testing and treatment for influenza, streptococcus A, and COVID-19 as defined in section 686D.2 at the point of interaction between a pharmacist and a patient.
(2) Point-of-care testing at the point of interaction between a pharmacist and a patient in response to a public health emergency.
2. A pharmacist ordering or administering a prescription drug, product, test, or treatment pursuant to subsection 1 shall do all of the following:
a. Maintain a record of all prescription drugs, products, tests, and treatments administered pursuant to this section.
b. Notify the patient’s primary health care provider of any prescription drugs, products, tests, or treatments administered to the patient, or enter such information in a patient record system also used by the primary health care provider, as permitted by the primary health care provider. If the patient does not have a primary health care provider, the pharmacist shall provide the patient with a written record of the prescription drugs, products, tests, or treatment provided to the patient and shall advise the patient to consult a physician.
c. Complete continuing pharmacy education related to statewide protocols recognized and approved by the board.
2018 Acts, ch 1142, §7; 2021 Acts, ch 103, §1, 2
Subsection 1, paragraph a, NEW subparagraph (7)
Subsection 1, NEW paragraph e
Structure Iowa Code
Section 155A.2 - Legislative declaration — purpose — exceptions.
Section 155A.2A - Board of pharmacy — alternate members.
Section 155A.6 - Pharmacist internship program.
Section 155A.6A - Pharmacy technician registration.
Section 155A.6B - Pharmacy support person registration.
Section 155A.7 - Pharmacist license.
Section 155A.8 - Requirements for pharmacist license.
Section 155A.9 - Approved colleges — graduates of foreign colleges.
Section 155A.10 - Display of pharmacist license.
Section 155A.11 - Renewal of pharmacist license.
Section 155A.12 - Pharmacist license — grounds for discipline.
Section 155A.13 - Pharmacy license.
Section 155A.13A - Nonresident pharmacy license — required, renewal, discipline.
Section 155A.13B - Pharmacy internet sites.
Section 155A.13C - Outsourcing facility license — renewal, cancellation, denial, discipline.
Section 155A.14 - Renewal of pharmacy license.
Section 155A.15 - Pharmacies — license required — discipline, violations, and penalties.
Section 155A.17 - Wholesale distributor license.
Section 155A.17A - Third-party logistics provider license.
Section 155A.19 - Notifications to board.
Section 155A.20 - Unlawful use of terms and titles — impersonation.
Section 155A.21 - Unlawful possession of prescription drug or device — penalty.
Section 155A.22 - General penalty.
Section 155A.23 - Prohibited acts.
Section 155A.25 - Burden of proof.
Section 155A.26 - Enforcement — agents as peace officers.
Section 155A.27 - Requirements for prescription.
Section 155A.28 - Label of prescription drugs — interchangeable biological product list.
Section 155A.29 - Prescription refills.
Section 155A.30 - Out-of-state prescription orders.
Section 155A.31 - Reference library.
Section 155A.32 - Drug product selection — restrictions.
Section 155A.33 - Delegation of functions.
Section 155A.33A - Technician product verification programs.
Section 155A.34 - Transfer of prescriptions.
Section 155A.35 - Patient medication records.
Section 155A.36 - Medication delivery systems.
Section 155A.37 - Code of professional responsibility for board employees.
Section 155A.38 - Dispensing drug samples.
Section 155A.40 - Criminal history record checks.
Section 155A.41 - Continuous quality improvement program.
Section 155A.42 - Limited distributor license.
Section 155A.43 - Pharmaceutical collection and disposal program — annual allocation.
Section 155A.44 - Vaccine and immunization administration.
Section 155A.45 - Reports — disclosure.
Section 155A.46 - Statewide protocols.
Section 155A.47 - Pilot or demonstration research projects.
Section 155A.48 - Collaborative pharmacy practice — agreements — payment.